Birkhäuser, Martin

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: No | Yes

No

Birkhäuser, H (2008). Editorials. Journal für gynäkologische Endokrinologie - Schweiz, 2(1) Gablitz (A): Krause & Pachernegg

Yes

Dhayat, Nasser; Marti, Nesa Magdalena; Kollmann, Zahraa; Bally, Lia Claudia; Escher, Geneviève; Grössl, Michael; Ackermann, Daniel; Mueller, Michael; Vogt, Bruno; Birkhäuser, Martin; Flück Pandey, Christa Emma (2018). Urinary steroid profiling in women hints at a diagnostic signature of the polycystic ovary syndrome: A pilot study considering neglected steroid metabolites. PLoS ONE, 13(10), e0203903. Public Library of Science 10.1371/journal.pone.0203903

Meier, Christian; Uebelhart, Brigitte; Aubry-Rozier, Bérengère; Birkhäuser, Martin; Bischoff-Ferrari, Heike A; Frey, Diana; Kressig, Reto W; Lamy, Olivier; Lippuner, Kurt; Stute, Petra; Suhm, Norbert; Ferrari, Serge (2017). Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO. Swiss medical weekly, 147(w14484), w14484. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14484

Nedeljkovic, Marko; Tian, Li; Ji, Ping; Déglon-Fischer, Agnès; Stute, Petra; Ocon, Erika; Birkhäuser, Martin; Ausfeld-Hafter, Brigitte (2013). Effects of acupuncture and Chinese herbal medicine (Zhi Mu 14) on hot flushes and quality of life in postmenopausal women: results of a four-arm randomized controlled pilot trial. Menopause - the journal of the North American Menopause Society, 21(1), pp. 15-24. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/GME.0b013e31829374e8

Birkhäuser, Martin (2013). Prevention of postmenopausal osteoporosis. Gynäkologische Endokrinologie, 11(4), pp. 289-298. Springer-Medizin-Verlag 10.1007/s10304-013-0551-9

Birkhäuser, Martin (2013). Prevention of postmenopausal osteoporosis. Gynäkologische Endokrinologie, 11(2), pp. 129-136. Springer-Medizin-Verlag 10.1007/s10304-013-0550-x

Birkhäuser, Martin (2013). Geriatric endocrinology. Gynäkologische Endokrinologie, 11(4), pp. 241-242. Springer-Medizin-Verlag 10.1007/s10304-013-0560-8

Lippuner, Kurt; Buchard, P A; De Geyter, C; Imthurn, B; Lamy, O; Litschgi, M; Luzuy, F; Schiessl, K; Stute, P; Birkhäuser, M (2012). Recommendations for raloxifene use in daily clinical practice in the Swiss setting. European spine journal, 21(12), pp. 2407-17. Berlin: Springer-Verlag 10.1007/s00586-012-2404-y

Birkhäuser, Martin (2010). Hormonal contraceptives of the second, third, and fourth generation. Gynäkologische Endokrinologie, 8(4), pp. 263-270. Springer-Medizin-Verlag 10.1007/s10304-010-0384-8

Birkäuser, M. (2010). Depression and estrogens. Gynäkologische Endokrinologie, 8(1), pp. 82-88. Springer-Medizin-Verlag 10.1007/s10304-009-0317-6

Birkhäuser, Martin (2010). On the situation of the three pillars of gynaecology. Gynäkologische Endokrinologie, 8(4), pp. 286-290. Springer-Medizin-Verlag 10.1007/s10304-010-0383-9

Riecher-Rössler, A.; Schmid, C.; Bleuer, S.; Birkhäuser, M. (2009). Antipsychotics and hyperprolactinaemia: pathophysiology, clinical significance, clarification and therapy. Gynäkologische Endokrinologie, 7(3), pp. 171-182. Springer-Medizin-Verlag 10.1007/s10304-009-0316-7

Bersinger, Nick A; Birkhäuser, Martin H; Wunder, Dorothea M (2006). Adiponectin as a marker of success in intracytoplasmic sperm injection/embryo transfer cycles. Gynecological endocrinology, 22(9), pp. 479-83. London: Informa Healthcare 10.1080/09537100600931316

Milsom, I; Lete, I; Bjertnaes, A; Rokstad, K; Lindh, I; Gruber, C J; Birkhäuser, M H; Aubeny, E; Knudsen, T; Bastianelli, C (2006). Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone. Human reproduction, 21(9), pp. 2304-11. Oxford: Oxford University Press 10.1093/humrep/del162

Birkhäuser, MH (2006). Die klinische Bedeutung von Gestagen-Partialwirkungen Gynäkologischer Endokrinologie. Gynecological endocrinology(4), pp. 42-64. London: Informa Healthcare

Birkhäuser, Martin (2006). Clinical significance of partial gestagen effects. Gynäkologische Endokrinologie, 4(1), pp. 52-64. Springer-Medizin-Verlag 10.1007/s10304-006-0139-8

Wunder, D.M.; Limoni, C.; Birkhäuser, M.H. (2005). Lack of seasonal variations in fertilization, pregnancy and implantation rates in women undergoing IVF. Human reproduction, 20(11), pp. 3122-3129. Oxford University Press 10.1093/humrep/dei177

Wunder, Dorothea M.; Mueller, Michael D.; Birkhäuser, Martin H.; Bersinger, Nick A. (2005). Steroids and protein markers in the follicular fluid as indicators of oocyte quality in patients with and without endometriosis. Journal of assisted reproduction and genetics, 22(6), pp. 257-264. Springer 10.1007/s10815-005-5149-2

Bersinger, N.A.; Meisser, A.; Bessou, T.; Seguin, P.; Birkhäuser, M.H.; Bischof, P. (1999). Production and characterization of monoclonal antibodies against pregnancy-associated plasma protein A. Molecular human reproduction MHR, 5(7), pp. 675-681. Oxford University Press 10.1093/molehr/5.7.675

Berger, E.; Chabloz, P.; De Quay, N.; Sann, A.; Walton, S.; Germond, M.; Birkhäuser, M. (1999). O-112. An open, randomized, group-comparative bi-centre study comparing recombinant FSH Follitropinum β 150 IU and highly purified urinary FSH 225 IU as a fixed dose regimen in IVF/ICSI treatment. Human reproduction, 14(Suppl 3), pp. 61-62. Oxford University Press 10.1093/humrep/14.Suppl_3.61-a

Bersinger, N A; Brandenberger, A; Berger, E; Baumann, C K; Birkhäuser, M H (1998). Serum pregnancy-specific beta1-glycoprotein before embryo transfer is related to endometrial thickness and to outcome prognosis in women undergoing in-vitro fertilization treatment. Human reproduction, 13(7), pp. 1962-1967. Oxford University Press 10.1093/humrep/13.7.1962

Brandenberger, Alfred W.; Bersinger, Nicolas A.; Huber, Peter R.; Berger, Elisabeth; Glanzmann, Patrick; Birkhäuser, Martin (1998). CA-125 Concentrations in the Serum and Pregnancy Outcome in IVF Cycles. Journal of assisted reproduction and genetics, 15(6), pp. 390-394. Springer 10.1023/A:1022589101648

Bersinger, N.A.; Brandenberger, A.; Birkhäuser, M.H. (1997). O-114. The presence of pregnancy-specific β1-glycoprotein in serum before embryo transfer is associated with lower endometrial thickness and poor pregnancy prognosis in IVF. Human reproduction, 12(Suppl 2), pp. 54-55. Oxford University Press 10.1093/humrep/12.Suppl_2.54-a

Bersinger, N.A.; Senn, A.; Chanson, A.; Germond, M.; Birkhäuser, M.H.; De Grandi, P. (1997). P-220. Significance of non-placental pregnancy-specific α1-glycoprotein in the serum of IVF cycles before and after embryo transfer. Human reproduction, 12(Suppl 2), p. 222. Oxford University Press 10.1093/humrep/12.Suppl_2.222

Berger, E.; Zakher, S.; Mueller, M.D.; Glanzman, P.; Brandenberger, A.; Bersinger, N.A.; Birkhäuser, M.H. (1997). R-044. Limiting the number of embryos transferred does not significantly influence the outcome of conventional IVF treatment. Human reproduction, 12(Suppl 2), pp. 255-256. Oxford University Press 10.1093/humrep/12.Suppl_2.255-b

Bersinger, N.A.; Brandenberger, A.W.; Birkhäuser, M.H. (1995). Implantation: Endometrial and placental protein markers and ovarian steroids in serum during in-vitro fertilization cycles. Human reproduction, 10(8), pp. 2149-2154. Oxford University Press 10.1093/oxfordjournals.humrep.a136251

Provide Feedback